April 2026 . 1. Product Overview Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. The 1 mg pen is a high-dose maintenance option primarily indicated for: Type 2 Diabetes Management: Improving blood sugar levels in adults. Cardiovascular Risk Reduction: Reducing the risk of major cardiovascular events like heart attack or stroke in patients with type 2 diabetes and established heart disease. Weight Management (Off-Label): While not its primary FDA-approved use, it is widely prescribed off-label for weight loss. 2. Pen Specifications & Dosing The 1 mg pen is designed for patients who have already completed the lower-dose initiation phase. Contents: One pre-filled pen contains
The 1 mg dose is typically a for patients who have already completed the initial titration phases (0.25 mg and 0.5 mg) but require further glycemic control. ozempic 1 mg pen
Semaglutide mimics the action of the natural hormone GLP-1. It works through three primary mechanisms: April 2026